NeuroTalk Support Groups - MBP8298 receives fast track designation from FDA

NeuroTalk Support Groups (https://www.neurotalk.org/)

- Multiple Sclerosis (https://www.neurotalk.org/multiple-sclerosis/)

- - MBP8298 receives fast track designation from FDA (https://www.neurotalk.org/multiple-sclerosis/53647-mbp8298-receives-fast-track-designation-fda.html)

MBP8298 receives fast track designation from FDA

We talked about this exciting drug opportunity in the following thread:

http://neurotalk.psychcentral.com/thread52769.html

... but the latest news is that it looks like it is getting fast-tracked for drug approval in the US:

Multiple Sclerosis drug dirucotide (MBP8298) receives fast track designation from FDA

BioMS Medical Corp. announced that the Food and Drug Administration (FDA) of the United States has granted fast track designation for the Company's lead drug, dirucotide (MBP8298), for the treatment of secondary progressive MS (SPMS). Dirucotide (MBP8298) is currently being evaluated in a U.S. pivotal phase III trial, named MAESTRO-03, at 68 sites with approximately 510 patients.

Fast track designation is an FDA status reserved for products that are intended to treat a serious or life-threatening condition and that demonstrate the potential to address unmet medical needs for that condition. Fast track designation can potentially facilitate development and expedite the review process.

"Our receipt of fast track designation for dirucotide in the U.S. is a significant milestone for both BioMS Medical and the MS community," said Kevin Giese, President and CEO of BioMS Medical. "Based on previous clinical results, we believe dirucotide is well-positioned to become a first-in-class treatment for secondary progressive MS patients, a large patient population with very limited treatment options."

Source: BioMS Medical Corp. (04/09/08)

http://www.msrc.co.uk/index.cfm?fuse...ow&pageid=1308

Cherie

Wow, that is exciting and good news!

I linked that to my friend who's mother is SPMS and bed ridden. I'm sure he'll be very happy to read this news. :)

While I believe this is possibly really good news, but this is another treatment to slow progression, not to repair damage. It is a glimmer of hope for SPMS and possibly others. I've heard it described as/ compared to "super Copaxone".

I posted this on the other thread on this drug too.

Here is some more information on dirucotide (somewhat from a business perspective). Published one month ago.

http://www.forbes.com/business/forbe.../0901/062.html

Is anyone participating in the trials? How are you feeling?

Theyve got to come up with a better name for it. Maybe we can start a contest?